⚒️ Ergon 全國專案數據平台 / 專案數據

Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)

案件編號 75dec25a-535a-41d1-b217-ffdd0efc5ee1
🤖 本頁數據由 Ergon AI 工作流(發現 → 真實瀏覽器採集 → 規格/AI 解析 → 附件加值)自動整理,僅供參考;申請資訊請以原始公告為準。

專案內容(AI 忠實提取,左)與原始公告頁(右)比對

View Grant Opportunity

General Information

Document Type Grants Notice
Funding Opportunity Number PAR-25-148
Funding Opportunity Title Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
Opportunity Category Discretionary
Opportunity Category Explanation
Funding Instrument Type Grant
Category of Funding Activity Education
Health
Income Security and Social Services
Category Explanation
Expected Number of Awards
Assistance Listings 93.172 -- Human Genome Research
93.173 -- Research Related to Deafness and Communication Disorders
93.233 -- National Center on Sleep Disorders Research
93.242 -- Mental Health Research Grants
93.273 -- Alcohol Research Programs
93.279 -- Drug Use and Addiction Research Programs
93.361 -- Nursing Research
93.393 -- Cancer Cause and Prevention Research
93.394 -- Cancer Detection and Diagnosis Research
93.395 -- Cancer Treatment Research
93.396 -- Cancer Biology Research
93.399 -- Cancer Control
93.837 -- Cardiovascular Diseases Research
93.838 -- Lung Diseases Research
93.839 -- Blood Diseases and Resources Research
93.840 -- Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders
93.865 -- Child Health and Human Development Extramural Research
93.866 -- Aging Research
93.867 -- Vision Research
Cost Sharing or Matching Requirement No
Version Synopsis 1
Posted Date Nov 21, 2024
Last Updated Date Nov 21, 2024
Original Closing Date for Applications Jan 07, 2028
Current Closing Date for Applications Jan 07, 2028
Archive Date Feb 12, 2028
Estimated Total Program Funding
Award Ceiling $
Award Floor $

Eligibility

Eligible Applicants Public and State controlled institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Private institutions of higher education
Additional Information on Eligibility Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name National Institutes of Health
Description The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students and enhancing the research environment at applicant institutions. Eligible institutions must award baccalaureate science degrees and have received no more than $6 million dollars per year of NIH support (in both direct and F and A/indirect costs) in 4 of the last 7 fiscal years. For institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of NIH funding received by all the non-health professional schools and colleges within the institution as a whole. This Notice of Funding Opportunity (NOFO) supports investigator-initiated mechanistic and/or minimal risk clinical trials addressing the mission and research interests of the participating NIH institutes. For the purpose of this NOFO, minimal risk clinical trials are defined as those that do not require FDA oversight, do not intend to formally establish efficacy, and have low risks to potentially cause physical or psychological harm.
Link to Additional Information https://grants.nih.gov/grants/guide/pa-files/PAR-25-148.html
Grantor Contact Information If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov

See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.

Similar Opportunities (identified by AI)

  • PAR-24-214
  • PAR-27-078
  • PAR-25-134
  • PAR-25-298
  • 23-601
原始公告頁(部分政府網站禁止內嵌,空白時請點右側連結) ↗ 新分頁開啟

正規化數據

類型計劃徵求 ・ 開放中
出資方National Institutes of Health
主辦/執行National Institutes of Health
領域標籤生醫健康文化與教育
申請期間📅 2024-11-21 ~ 2028-01-07
公告日期(未取得)
經費(未取得)
申請資格
  1. Public and State controlled institutions of higher education
  2. Private institutions of higher education
  3. Alaska Native and Native Hawaiian Serving Institutions
  4. Asian American Native American Pacific Islander Serving Institutions (AANAPISISs)
  5. Hispanic-serving Institutions
  6. Historically Black Colleges and Universities (HBCUs)
  7. Tribally Controlled Colleges and Universities (TCCUs)
摘要

The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students and enhancing the research environment at applicant institutions. Eligible institutions must award baccalaureate science degrees and have received no more than $6 million dollars per year of NIH support (in both direct and F and A/indirect costs) in 4 of the last 7 fiscal years. For institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of NIH funding received by all the non-health professional schools and colleges within the institution as a whole. This Notice of Funding Opportunity (NOFO) supports investigator-initiated mechanistic and/or minimal risk clinical trials addressing the mission and research interests of the participating NIH institutes. For the purpose of this NOFO, minimal risk clinical trials are defined as those that do not require FDA oversight, do not intend to formally establish efficacy, and have low risks to potentially cause physical or psychological harm.

入庫時間2026-08-17 08:50 ・ 最近重訪 2026-08-17 08:50

附件(0)

此專案沒有已確認內容的附件。
Ergon 為實驗性服務・回數據平台首頁・個別案件請以原始公告為準